Asia Deal Watch: Astellas Looks To Next-Gen AAV Vectors Despite Gene Therapy Clinical Setbacks

 
• By Ian Haydock, Anju Ghangurde, Dexter Jie Yan, Jung Won Shin, and Joseph Haas

Astellas inks agreement with Dyno Therapeutics for access to its CapsidMap platform for novel AAV vectors. Taiho takes option to Arcus TIGIT-targeted antibody candidates.

Asia Deal Watch

More from Deal Watch

More from Deals